Is Enhancer Function Driven by Protein–Protein Interactions? From Bacteria to Leukemia
BioEssays · 2025
DOI: 10.1002/bies.70006 ↗At a glance
Übersichtsarbeit in BioEssays, 2025. Written by Nicholas T Crump and 1 co-authors. Institution: Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, …. Major MEDLINE topics: Enhancer Elements, Genetic, Leukemia, Bacteria. Cited 1 times so far (Crossref); 120 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: UKRI, Kay Kendall Leukaemia Fund Intermediate Fellowship.
Abstract (original language)
The precise regulation of the transcription of genes is essential for normal development and for the maintenance of life. Aberrant gene expression changes drive many human diseases. Despite this, we still do not completely understand how precise gene regulation is controlled in living systems. Enhancers are key regulatory elements that enable cells to specifically activate genes in response to environmental cues, or in a stage or tissue‐specific manner. Any model of enhancer activity needs to answer two main questions: (1) how enhancers are able to identify and act on specific genes and (2) how enhancers influence transcription. To address these points, we first outline some of the basic principles that can be established from simpler prokaryotic systems, then discuss recent work on aberrant enhancer activity in leukemia. We argue that highly specific protein–protein interactions are a key driver of enhancer‐promoter proximity, allowing enhancer‐bound factors to directly act on RNA polymerase and activate transcription.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, UK.
- MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
ORCID profiles: Nicholas T Crump, Thomas A Milne
Funding
- UKRI
- Kay Kendall Leukaemia Fund Intermediate Fellowship
Cite
APA
Crump, N. T., & Milne, T. A. (2025). Is Enhancer Function Driven by Protein–Protein Interactions? From Bacteria to Leukemia. BioEssays. https://doi.org/10.1002/bies.70006
Vancouver
Crump NT, Milne TA. Is Enhancer Function Driven by Protein–Protein Interactions? From Bacteria to Leukemia. BioEssays. 2025. doi:10.1002/bies.70006
BibTeX
@article{Crump2025,
author = {Crump, Nicholas T and Milne, Thomas A},
title = {Is Enhancer Function Driven by Protein–Protein Interactions? From Bacteria to Leukemia},
journal = {BioEssays},
year = {2025},
doi = {10.1002/bies.70006}
}
EUVIMED